Scaling QC Beyond LIMS

LIMS manages samples; LES manages work. In regulated quality control environments, from pharma and biotech to CDMOs, medical devices, specialty chemicals, and CPG, standard LIMS solutions often fall short when it comes to step-by-step laboratory procedure execution. When static systems stall, site rollouts lose momentum and tech transfers slow down the product launches that matter most.

In this session, we’ll explore real-world deployment strategies and demonstrate how an activity-based Lab Execution System (LES) architecture with BIOVIA ONE Lab enables rapid multi-site scaling, seamless method authoring, and right-first-time execution, complementing the LIMS investments you’ve already made.

Who Should Attend

• QC Directors, Heads of Quality Control, and Lab Managers
• QC Operations and Site Quality leaders across pharma, biotech, CDMOs, and other regulated industries
• Laboratory Informatics and LIMS owners and architects

Ideal if you are:

• Planning or already running a LIMS and hitting limits with procedure execution
• Preparing a multi-site rollout or consolidating lab systems
• Under pressure to compress tech transfer timelines for upcoming launches